Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.

Respiratory medicine - 1 Nov 2023

Rogers Linda, Jesenak Milos, Bjermer Leif, Hanania Nicola A, Seys Sven F, Diamant Zuzana

Abstract excerpt

The development of monoclonal antibody therapies targeting specific components of the pathways relevant to asthma pathophysiology has revolutionized treatment of severe asthma both in adults and children and helped to further unravel the heterogeneity of this disease. However, the availability of multiple agents, often with overlapping eligibility criteria, creates a need for pragmatic guidance for specialists...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Asthma
Share to Biological Products

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Phenotype

Share to Precision Medicine

Source

Identifiers

PMID: 37776915
DOI: 10.1016/j.rmed.2023.107414

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.PMID 37776915Read ↗

Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.Semantic proximity Read ↗

Biologics in severe asthma: the overlap endotype - opportunities and challenges.Semantic proximity Read ↗

EAACI Biologicals Guidelines-Recommendations for severe asthma.Semantic proximity Read ↗

Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted ApproachSemantic proximity Read ↗

Controversies and opportunities in severe asthma.Semantic proximity Read ↗

Diagnosis and treatment of severe asthma: a phenotype-based approach.Semantic proximity Read ↗

Targeted therapeutics for severe refractory asthma: monoclonal antibodies.Semantic proximity Read ↗

Moving toward consensus on diagnosis and management of severe asthma in adults.Semantic proximity Read ↗

Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.Semantic proximity Read ↗

Severe asthma and personalized approach in the choice of biologic.Semantic proximity Read ↗

Asthma Phenotypes in the Era of Personalized MedicineSemantic proximity Read ↗

New approaches for identifying and testing potential new anti-asthma agents.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.